New shipNational Healthcare $NHC
Grew revenue 16.1% in FY2025 to $1.5 billion, operating margin 8.5% against a 2.0% median for skilled nursing care facilities, equity 70.0% of assets, and dividend per share up 12 years running.
Last filing8-K · Item 2.02 Results of Operations and Financial Condition, 6 Nov 2026
Edgarette’s full reading · exposure, experience, soundness, credibility, range
🫧 Edgar looked up NATIONAL HEALTHCARE CORP ($NHC). Last filing: 8-K (2.02 Results of Operations and Financial Condition), 2026-11-06. 15 event filings (8-K) in the past twelve months. Auditor change (8-K Item 4.01) filed 2025-04-08.
🔖 Exposure: revenue $1.5B (FY2025), total debt $40.0M. Experience: revenue up 16.1% on the year, up 9.0% a year over 4 years; operating margin 8.5%, up from 6.9%. Soundness: equity 70.0% of assets, return on equity 11.5%, payout 31.6% of profit, dividend per share up 12 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $1.5B and $1.9B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $1.4B to $2.0B. A statistical range, not company guidance. Against peers (54 filers, $50M+ revenue, its industry group): operating margin 8.5% against a 2.0% median; growth 16.1% against 13.0%.
Read from its own SEC filings · nothing written, nothing inferred
Gold paid out, navy kept. Kept share × return on equity = the growth it can fund itself. Facts from the filings, not a recommendation.
Speed and cash · fiscal 2025
Both views must agree for a label · a description, not advice.
| Cash flow (op · inv · fin · free) | $185M · −$34M · −$136M · $149M |
| Investment book (cash · short · long) | $93M · $14M · $109M · current ratio 1.82 · unrealized −$1M |
| Revenue swing · equity of assets | 6.7% · 70.0% |
National Healthcare is growing faster than its size class, with steadier revenue. Its own audited SEC figures.
The figures, as filed
| Fiscal year end | 2025-12-31 |
| Revenue | $1.5B |
| Revenue, on the year | 16.1% |
| Revenue, a year over the record | 9.0% |
| Operating margin | 8.5% |
| Operating margin, prior year | 6.9% |
| Net margin | 8.1% |
| Research and development | not filed separately |
| Total debt | $40M |
| Equity of assets | 70.0% |
| Return on equity | 11.5% |
| Payout of profit | 31.6% |
| Dividend per share | $2.53 · up 12 years running |
| Earnings per share | $7.76 |
| Book value per share | $68.31 |
| Revenue per share | $97.01 |
| Shares outstanding | 15,646,338 |
| Audited years read | 5 |
Peers: the median of 54 filers with $50M+ revenue in services-skilled nursing care facilities.
Classic signals · fiscal 2025Altman Z″ 5.72 safe zone 1968Piotroski F 8 of 9 strong 2000Beneish M not enough filed detail (needs receivables, cost of revenue, PP&E, depreciation, SG&A for two years)Sloan accruals -4.1% earnings backed by cash 1996DuPont ROE 12% = margin 8.1% × turns 0.99 × leverage 1.49
What a terminal subscription used to buy, a filing and arithmetic now give anyone. Published method, from the same filings. Display only: nothing here moves the range or its receipt. Why? →
Health HarborNational Healthcare sails as: New ship
Health watch · 12 monthsDirector or officer change ×2
Sailing speed follows growth: 11.8% a year crosses the harbor in 45 seconds.
🌊 Visit the Bay →No warning signs on the measures below.
Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an operating loss; negative free cash flow outside regulated utilities; an 80% revenue range of ±25% or wider. A picture of the signs, not a rating and not investment advice.
- 8-K · 2026-11-06 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits
- 8-K · 2026-11-06 · 8.01 Other Events; 9.01 Financial Statements and Exhibits
- 10-Q · 2026-11-05
- 8-K · 2026-08-11 · 8.01 Other Events; 9.01 Financial Statements and Exhibits
- 8-K · 2026-08-11 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits
- 10-Q · 2026-08-06
Measured, not prophesiedSuccess tools: score it, compare it, see its fieldFour questions. Scored against the SEC filings of the companies in your field.
Each benchmark is the median of SEC filers in your industry code, from their own audited filings, read on the filing boards. Reporting, not investment advice.
Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price. Reporting, not investment advice. No price targets and no trading recommendations. Figures from the SEC’s own data · every filing · this page as JSON · Open in Excel (CSV) · Ten-year table (CSV) ·